Nitric oxide and redox regulation in the liver: Part II. Redox biology in pathologic hepatocytes and implications for intervention

Journal of Surgical Research

Volumn 167, Issue 1, 2011, Pages 96-112

  Diesen, Diana L ^a   Kuo, Paul C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ethanol induced hepatitis; hepatitis; hepatocytes; nitric oxide; oxidative stress; reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; ALPHA TOCOPHEROL; AMINOGUANIDINE; ANTIOXIDANT; APOLIPOPROTEIN A1; ASCORBIC ACID; BUCILLAMINE; CYANIDIN 3 GLUCOSIDE; DEFEROXAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GRANULOCYTE COLONY STIMULATING FACTOR; GREEN TEA EXTRACT; IDEBENONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LONG CHAIN FATTY ACID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PARACETAMOL; QUERCETIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID; TRIMETAZIDINE; TUMOR NECROSIS FACTOR ALPHA; UBIQUINONE; UNINDEXED DRUG; VASCULOTROPIN;

ALCOHOL LIVER DISEASE; AMINO ACID SEQUENCE; ANTIOXIDANT ACTIVITY; APOPTOSIS; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL GROWTH; CELL REGENERATION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; HEMORRHAGIC SHOCK; HEPATITIS; HUMAN; INFLAMMATION; IRON OVERLOAD; KUPFFER CELL; LIVER CELL; LIVER FAILURE; LIVER FIBROSIS; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MULTIPLE ORGAN FAILURE; NECROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDOX STRESS; REPERFUSION INJURY; REVIEW; SEPSIS; STELLATE CELL; TOXIC HEPATITIS; WILSON DISEASE;

ANTIOXIDANTS; HEPATOCYTES; HUMANS; LIVER; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEOMICS;

EID: 79953036451     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.10.006     Document Type: Review

References (185)

1. T.A. Churchill, K.M. Cheetham, and B.J. Fuller Glycolysis and energy metabolism in rat liver during warm and cold ischemia: evidence of an activation of the regulatory enzyme phosphofructokinase Cryobiology 31 1994 441
2. M. Pocard, A. Vincent-Salomon, and J. Girodet Effects of preoperative chemotherapy on liver function tests after hepatectomy Hepatogastroenterology 48 2001 1406
3. B. Fellstrom, L.M. Akuyrek, and U. Backman Postischemic reperfusion injury and allograft arteriosclerosis Transplant Proc 30 1998 4278
4. J.M. McCord Oxygen-derived free radicals in postischemic tissue injury N Engl J Med 312 1985 159
5. H. Blum, M.D. Osbakken, and R.G. Johnson Jr. Sodium flux and bioenergetics in the ischemic rat liver Magn Reson Med 18 1991 348
6. D.K. Dhar, Y. Takemoto, and N. Nagasue FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver J Surg Res 60 1996 142
7. J.L. Farber The role of calcium in cell death Life Sci 29 1981 1289
8. J.S. Kim, L. He, and J.J. Lemasters Mitochondrial permeability transition: a common pathway to necrosis and apoptosis Biochem Biophys Res Commun 304 2003 463
9. G. Zahrebelski, A.L. Nieminen, and K. al-Ghoul Progression of subcellular changes during chemical hypoxia to cultured rat hepatocytes: a laser scanning confocal microscopic study Hepatology 21 1995 1361
10. C. Fan, R.M. Zwacka, and J.F. Engelhardt Therapeutic approaches for ischemia/reperfusion injury in the liver J Mol Med 77 1999 577
11. H. Jaeschke Reactive oxygen and ischemia/reperfusion injury of the liver Chem Biol Interact 79 1991 115
12. T.D. Engerson, T.G. McKelvey, and D.B. Rhyne Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues J Clin Invest 79 1987 1564
13. M. Ozaki, S. Suzuki, and K. Irani Redox factor-1/APE suppresses oxidative stress by inhibiting the rac1 GTPase FASEB J 16 2002 889
14. S.J. Weiss Tissue destruction by neutrophils N Engl J Med 320 1989 365
15. R.M. Zwacka, Y. Zhang, and J. Halldorson CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver J Clin Invest 100 1997 279
16. G.M. Hur, Y.S. Ryu, and H.Y. Yun Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kappaB Biochem Biophys Res Commun 261 1999 917
17. M. Isobe, T. Katsuramaki, and K. Hirata Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver Transplantation 68 1999 803
18. T. Ikeda, K. Yanaga, and K. Kishikawa Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats Hepatology 16 1992 454
19. V.G. Lee, M.L. Johnson, and J. Baust The roles of iNOS in liver ischemia-reperfusion injury Shock 16 2001 355
20. H. Kobayashi, T. Nonami, and T. Kurokawa Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver J Surg Res 59 1995 772
21. Y. Wang, W.R. Mathews, and D.M. Guido Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia Shock 4 1995 282
22. M. Meguro, T. Katsuramaki, and H. Kimura Apoptosis and necrosis after warm ischemia-reperfusion injury of the pig liver and their inhibition by ONO-1714 Transplantation 75 2003 703
23. C. Szabo Multiple pathways of peroxynitrite cytotoxicity Toxicol Lett 140-141 2003 105
24. P.T. Doulias, A. Barbouti, and D. Galaris SIN-1-induced DNA damage in isolated human peripheral blood lymphocytes as assessed by single cell gel electrophoresis (comet assay) Free Radic Biol Med 30 2001 679
25. R.S. McCuskey Morphological mechanisms for regulating blood flow through hepatic sinusoids Liver 20 2000 3
26. Z. Ming, C. Han, and W.W. Lautt Nitric oxide mediates hepatic arterial vascular escape from norepinephrine-induced constriction Am J Physiol 277 1999 G1200
27. T.W. Gauthier, K.L. Davenpeck, and A.M. Lefer Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion Am J Physiol 267 1994 G562
28. M.K. Mittal, T.K. Gupta, and F.Y. Lee Nitric oxide modulates hepatic vascular tone in normal rat liver Am J Physiol 267 1994 G416
29. M.W. Radomski, R.M. Palmer, and S. Moncada Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium Lancet 2 1987 1057
30. P. Kubes, M. Suzuki, and D.N. Granger Nitric oxide: an endogenous modulator of leukocyte adhesion Proc Natl Acad Sci USA 88 1991 4651
31. S. Kanwar, B.L. Tepperman, and D. Payne Time course of nitric oxide production and epithelial dysfunction during ischemia/reperfusion of the feline small intestine Circ Shock 42 1994 135
32. I.N. Hines, S. Kawachi, and H. Harada Role of nitric oxide in liver ischemia and reperfusion injury Mol Cell Biochem 234-235 2002 229
33. M.R. Duranski, J.W. Elrod, and J.W. Calvert Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury Am J Physiol Heart Circ Physiol 291 2006 H2980
34. S.P. Jones, J.J. Greer, and A.K. Kakkar Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury Am J Physiol Heart Circ Physiol 286 2004 H276
35. J.W. Elrod, M.R. Duranski, and W. Langston eNOS gene therapy exacerbates hepatic ischemia-reperfusion injury in diabetes: a role for eNOS uncoupling Circ Res 99 2006 78
36. R. Varadarajan, L. Golden-Mason, and L. Young Nitric oxide in early ischaemia reperfusion injury during human orthotopic liver transplantation Transplantation 78 2004 250
37. J.D. Lang Jr., X. Teng, and P. Chumley Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation J Clin Invest 117 2007 2583
38. D. Uhlmann, S. Uhlmann, and H.U. Spiegel Endothelin/nitric oxide balance influences hepatic ischemia-reperfusion injury J Cardiovasc Pharmacol 36 2000 S212
39. D. Uhlmann, S. Scommotau, and H. Witzigmann Exogenous L-arginine protects liver microcirculation from ischemia reperfusion injury Eur Surg Res 30 1998 175
40. H. Katsumi, M. Nishikawa, and F. Yamashita Prevention of hepatic ischemia/reperfusion injury by prolonged delivery of nitric oxide to the circulating blood in mice Transplantation 85 2008 264
41. D.A. Geller, S.H. Chia, and Y. Takahashi Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation JPEN J Parenter Enteral Nutr 25 2001 142
42. J.V. Rodriguez, E.E. Guibert, and A. Quintana Role of sodium nitroprusside in the improvement of rat liver preservation in University of Wisconsin solution: A study in the isolated perfused liver model J Surg Res 87 1999 201
43. C. Hierholzer, B.G. Harbrecht, and T.R. Billiar Hypoxia-inducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events in hemorrhagic shock Arch Orthop Trauma Surg 121 2001 219
44. C. Hierholzer, and T.R. Billiar Molecular mechanisms in the early phase of hemorrhagic shock Langenbecks Arch Surg 386 2001 302
45. K. Guillemin, and M.A. Krasnow The hypoxic response: huffing and HIFing Cell 89 1997 9
46. C. Hierholzer, E. Kelly, and T.R. Billiar Granulocyte colony-stimulating factor (G-CSF) production in hemorrhagic shock requires both the ischemic and resuscitation phase Arch Orthop Trauma Surg 116 1997 173
47. C. Hierholzer, J.C. Kalff, and L. Omert Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury Am J Physiol 275 1998 L611
48. C. Hierholzer, B. Harbrecht, and J.M. Menezes Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock J Exp Med 187 1998 917
49. C. Hierholzer, J.C. Kalff, and T.R. Billiar Activation of STAT proteins following ischemia reperfusion injury demonstrates a distinct IL-6 and G-CSF mediated profile Transplant Proc 30 1998 2647 (Pubitemid 28459784)
50. T.C. Hua, and S.M. Moochhala Influence of L-arginine, aminoguanidine, and NG-nitro-L-arginine methyl ester (L-name) on the survival rate in a rat model of hemorrhagic shock Shock 11 1999 51
51. M.C. McDonald, M. Izumi, and S. Cuzzocrea A novel, potent and selective inhibitor of the activity of inducible nitric oxide synthase (GW274150) reduces the organ injury in hemorrhagic shock J Physiol Pharmacol 53 2002 555
52. J.M. Menezes, C. Hierholzer, and S.C. Watkins The modulation of hepatic injury and heat shock expression by inhibition of inducible nitric oxide synthase after hemorrhagic shock Shock 17 2002 13
53. K. Daughters, K. Waxman, and H. Nguyen Increasing nitric oxide production improves survival in experimental hemorrhagic shock Resuscitation 31 1996 141
54. J. Menezes, C. Hierholzer, and S.C. Watkins A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock Am J Physiol 277 1999 G144
55. C. Hierholzer, J.M. Menezes, and A. Ungeheuer A nitric oxide scavenger protects against pulmonary inflammation following hemorrhagic shock Shock 17 2002 98
56. C. Bauer, W. Kuntz, and F. Ohnsmann The attenuation of hepatic microcirculatory alterations by exogenous substitution of nitric oxide by s-nitroso-human albumin after hemorrhagic shock in the rat Shock 21 2004 165
57. B.S. Taylor, L.H. Alarcon, and T.R. Billiar Inducible nitric oxide synthase in the liver: regulation and function Biochemistry (Mosc) 63 1998 766
58. P. Muriel Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride Biochem Pharmacol 56 1998 773
59. S. Mellouk, S.J. Green, and C.A. Nacy IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism J Immunol 146 1991 3971
60. A. Nussler, J.C. Drapier, and L. Renia L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation Eur J Immunol 21 1991 227
61. T.R. Billiar, R.D. Curran, and B.G. Harbrecht Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage J Leukoc Biol 48 1990 565
62. B.G. Harbrecht, T.R. Billiar, and J. Stadler Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury J Leukoc Biol 52 1992 390
63. B.G. Harbrecht, T.R. Billiar, and J. Stadler Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia Crit Care Med 20 1992 1568
64. T.P. Huang, T. Nishida, and W. Kamike Role of nitric oxide in oxygen transport in rat liver sinusoids during endotoxemia Hepatology 26 1997 336
65. K. Kamiya, T. Kono, and J. Iwamoto The cytoprotective role of lipopolysaccharide-induced nitric oxide against liver damage during early phase of endotoxemia in rats Shock 14 2000 229
66. J. Ou, T.M. Carlos, and S.C. Watkins Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia Nitric Oxide 1 1997 404
67. M.J. Hickey, K.A. Sharkey, and E.G. Sihota Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia FASEB J 11 1997 955
68. G. Sass, K. Koerber, and R. Bang Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice J Clin Invest 107 2001 439
69. E.P. Nadler, E.C. Dickinson, and D. Beer-Stolz Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge Am J Physiol Gastrointest Liver Physiol 281 2001 G173
70. G. Cotter, E. Kaluski, and O. Milo LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study Eur Heart J 24 2003 1287
71. A. Petros, G. Lamb, and A. Leone Effects of a nitric oxide synthase inhibitor in humans with septic shock Cardiovasc Res 28 1994 34
72. A. Lopez, J.A. Lorente, and J. Steingrub Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock Crit Care Med 32 2004 21
73. J.H. Alexander, H.R. Reynolds, and A.L. Stebbins Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial JAMA 297 2007 1657
74. I. Kurose, H. Higuchi, and S. Miura Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication Hepatology 25 1997 368
75. E. Zamara, E. Novo, and F. Marra 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells J Hepatol 40 2004 60
76. W. Ekataksin, and K. Kaneda Liver microvascular architecture: an insight into the pathophysiology of portal hypertension Semin Liver Dis 19 1999 359
77. V. Ratziu, A. Lalazar, and L. Wong Zf9, a Kruppel-like transcription factor up-regulated in vivo during early hepatic fibrosis Proc Natl Acad Sci U S A 95 1998 9500
78. E. Olaso, K. Ikeda, and F.J. Eng DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells J Clin Invest 108 2001 1369
79. O. Vinas, R. Bataller, and P. Sancho-Bru Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation Hepatology 38 2003 919
80. V. Shah, M. Toruner, and F. Haddad Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat Gastroenterology 117 1999 1222
81. J. Gracia-Sancho, B. Lavina, and A. Rodriguez-Vilarrupla Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability Hepatology 47 2008 1248
82. M. Koruk, H. Aksoy, and F. Akcay Antioxidant capacity and nitric oxide in patients with hepatic cirrhosis Ann Clin Lab Sci 32 2002 252
83. B.R. Bacon, and R.S. Britton The pathology of hepatic iron overload: a free radical-mediated process? Hepatology 11 1990 127
84. H. Tsukamoto, W. Horne, and S. Kamimura Experimental liver cirrhosis induced by alcohol and iron J Clin Invest 96 1995 620
85. G. Poli, M.U. Dianzani, and K.H. Cheeseman Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions Biochem J 227 1985 629
86. O. Niemela, S. Parkkila, and R.S. Britton Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury J Lab Clin Med 133 1999 451
87. S.P. Hussain, K. Raja, and P.A. Amstad Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases Proc Natl Acad Sci USA 97 2000 12770
88. M. Ohhira, T. Ohtake, and A. Matsumoto Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases Alcohol Clin Exp Res 22 1998 145S
89. B.R. Bacon, R. O'Neill, and R.S. Britton Hepatic mitochondrial energy production in rats with chronic iron overload Gastroenterology 105 1993 1134
90. K. Park, K.Y. Chung, and S.H. Sung Protective effect of desferrioxamine during canine liver transplantation: significance of peritransplant liver biopsy Transplant Proc 35 2003 117
91. A. Pietrangelo, E. Rocchi, and L. Schiaffonati Liver gene expression during chronic dietary iron overload in rats Hepatology 11 1990 798
92. I.S. Young, T.G. Trouton, and J.J. Torney Antioxidant status and lipid peroxidation in hereditary haemochromatosis Free Radic Biol Med 16 1994 393
93. A. Pietrangelo, F. Borella, and G. Casalgrandi Antioxidant activity of silybin in vivo during long-term iron overload in rats Gastroenterology 109 1995 1941
94. K. Houglum, P. Bedossa, and M. Chojkier TGF-beta and collagen-alpha 1 (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload Am J Physiol 267 1994 G908
95. C. Niederau, R. Fischer, and A. Sonnenberg Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis N Engl J Med 313 1985 1256
96. A.J. Marrogi, M.A. Khan, and H.E. van Gijssel Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma J Natl Cancer Inst 93 2001 1652
97. H. Ogihara, T. Ogihara, and M. Miki Plasma copper and antioxidant status in Wilson's disease Pediatr Res 37 1995 219
98. R.J. Sokol, D. Twedt, and J.M. McKim Jr. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis Gastroenterology 107 1994 1788
99. J. Nair, P.L. Carmichael, and R.C. Fernando Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis Cancer Epidemiol Biomarkers Prev 7 1998 435
100. J.S. Gujral, T.R. Knight, and A. Farhood Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis? Toxicol Sci 67 2002 322
101. M. Black Acetaminophen hepatotoxicity Annu Rev Med 35 1984 577
102. B. Halliwell, and J. Gutteridge Free Radicals in Biology and Medicine 2007 Oxford University Press oxford
103. Y. Qiu, L.Z. Benet, and A.L. Burlingame Identification of the hepatic protein targets of reactive metabolites of acetaminophen in vivo in mice using two-dimensional gel electrophoresis and mass spectrometry J Biol Chem 273 1998 17940
104. D.L. Laskin, and A.M. Pilaro Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver Toxicol Appl Pharmacol 86 1986 204
105. D.L. Laskin, A.M. Pilaro, and S. Ji Potential role of activated macrophages in acetaminophen hepatotoxicity. II. Mechanism of macrophage accumulation and activation Toxicol Appl Pharmacol 86 1986 216
106. J.A. Hinson, S.L. Pike, and N.R. Pumford Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice Chem Res Toxicol 11 1998 604
107. J.A. Hinson, S.L. Michael, and S.G. Ault Western blot analysis for nitrotyrosine protein adducts in livers of saline-treated and acetaminophen-treated mice Toxicol Sci 53 2000 467
108. S.L. Michael, N.R. Pumford, and P.R. Mayeux Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species Hepatology 30 1999 186
109. T.R. Knight, A. Kurtz, and M.L. Bajt Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress Toxicol Sci 62 2001 212
110. C.R. Gardner, D.E. Heck, and C.S. Yang Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat Hepatology 27 1998 748
111. C.R. Gardner, J.D. Laskin, and D.M. Dambach Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10 Toxicol Appl Pharmacol 184 2002 27
112. J. Liu, C. Li, and M.P. Waalkes The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice Hepatology 37 2003 324
113. J.O. Miners, R. Drew, and D.J. Birkett Mechanism of action of paracetamol protective agents in mice in vivo Biochem Pharmacol 33 1984 2995
114. A.R. Buckpitt, D.E. Rollins, and J.R. Mitchell Varying effects of sulfhydryl nucleophiles on acetaminophen oxidation and sulfhydryl adduct formation Biochem Pharmacol 28 1979 2941
115. J.H. Lin, and G. Levy Sulfate depletion after acetaminophen administration and replenishment by infusion of sodium sulfate or N-acetylcysteine in rats Biochem Pharmacol 30 1981 2723
116. P.M. Harrison, R. Keays, and G.P. Bray Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine Lancet 335 1990 1572
117. R. Keays, P.M. Harrison, and J.A. Wendon Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial BMJ 303 1991 1026
118. P.M. Harrison, J.A. Wendon, and A.E. Gimson Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure N Engl J Med 324 1991 1852
119. M.J. Czaja, H. Liu, and Y. Wang Oxidant-induced hepatocyte injury from menadione is regulated by ERK and AP-1 signaling Hepatology 37 2003 1405
120. L. Tacchini, L. Radice, and G. Pogliaghi Differential activation of heat shock and nuclear factor kappaB transcription factors in postischemic reperfused rat liver Hepatology 26 1997 186
121. K.T. Morgan, H. Ni, and H.R. Brown Application of cDNA microarray technology to in vitro toxicology and the selection of genes for a real-time RT-PCR-based screen for oxidative stress in Hep-G2 cells Toxicol Pathol 30 2002 435
122. I. Paron, A. D'Elia, and C. D'Ambrosio A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells Biochem J 378 2004 929
123. C. Vascotto, L. Cesaratto, and C. D'Ambrosio Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation Proteomics 6 2006 3455
124. C. Avellini, U. Baccarani, and G. Trevisan Redox proteomics and immunohistology to study molecular events during ischemia-reperfusion in human liver Transplant Proc 39 2007 1755
125. G.K. Glantzounis, H.J. Salacinski, and W. Yang The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: a review Liver Transpl 11 2005 1031
126. G. Wenzel, B. Kuklinski, and C. Ruhlmann [Alcohol-induced toxic hepatitis-a "free radical" associated disease. Lowering fatality by adjuvant antioxidant therapy] Z Gesamte Inn Med 48 1993 490
127. M. Phillips, H. Curtis, and B. Portmann Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis-a randomised clinical trial J Hepatol 44 2006 784
128. S. Stewart, M. Prince, and M. Bassendine A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis J Hepatol 47 2007 277
129. M.P. de la Maza, M. Petermann, and D. Bunout Effects of long-term vitamin E supplementation in alcoholic cirrhotics J Am Coll Nutr 14 1995 192
130. E. Mezey, J.J. Potter, and L. Rennie-Tankersley A randomized placebo controlled trial of vitamin E for alcoholic hepatitis J Hepatol 40 2004 40
131. E.R. Miller 3rd, R. Pastor-Barriuso, and D. Dalal Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality Ann Intern Med 142 2005 37
132. J.M. Mato, J. Camara, and J. Fernandez de Paz S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial J Hepatol 30 1999 1081
133. G.E. Pamuk, and A. Sonsuz N-acetylcysteine in the treatment of non-alcoholic steatohepatitis J Gastroenterol Hepatol 18 2003 1220
134. J.E. Lavine Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study J Pediatr 136 2000 734
135. S.A. Harrison, S. Torgerson, and P. Hayashi Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis Am J Gastroenterol 98 2003 2485
136. A.J. Sanyal, P.S. Mofrad, and M.J. Contos A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis Clin Gastroenterol Hepatol 2 2004 1107
137. P. Vajro, C. Mandato, and A. Franzese Vitamin E treatment in pediatric obesity-related liver disease: a randomized study J Pediatr Gastroenterol Nutr 38 2004 48
138. F. Lirussi, L. Azzalini, and S. Orando Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis Cochrane Database Syst Rev 2007 CD004996
139. A. von Herbay, W. Stahl, and C. Niederau Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study Free Radic Res 27 1997 599
140. M.P. Look, A. Gerard, and G.S. Rao Interferon/antioxidant combination therapy for chronic hepatitis C-a controlled pilot trial Antiviral Res 43 1999 113
141. A. Melhem, M. Stern, and O. Shibolet Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial J Clin Gastroenterol 39 2005 737
142. E. Gabbay, E. Zigmond, and O. Pappo Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial World J Gastroenterol 13 2007 5317
143. R. Brigelius-Flohe, F.J. Kelly, and J.T. Salonen The European perspective on vitamin E: current knowledge and future research Am J Clin Nutr 76 2002 703
144. K.G. Calfee-Mason, B.T. Spear, and H.P. Glauert Vitamin E inhibits hepatic NF-kappaB activation in rats administered the hepatic tumor promoter, phenobarbital J Nutr 132 2002 3178
145. R. Ricciarelli, J.M. Zingg, and A. Azzi The 80th anniversary of vitamin E: beyond its antioxidant properties Biol Chem 383 2002 457
146. H. Masaki, Y. Okano, and Y. Ochiai alpha-tocopherol increases the intracellular glutathione level in HaCaT keratinocytes Free Radic Res 36 2002 705
147. S. Marubayashi, K. Dohi, and K. Yamada Changes in the levels of endogenous coenzyme Q homologs, alpha-tocopherol, and glutathione in rat liver after hepatic ischemia and reperfusion, and the effect of pretreatment with coenzyme Q10 Biochim Biophys Acta 797 1984 1
148. K. Soltys, G. Dikdan, and B. Koneru Oxidative stress in fatty livers of obese Zucker rats: rapid amelioration and improved tolerance to warm ischemia with tocopherol Hepatology 34 2001 13
149. G.E. Gondolesi, N. Lausada, and G. Schinella Reduction of ischemia-reperfusion injury in parenchymal and nonparenchymal liver cells by donor treatment with DL-alpha-tocopherol prior to organ harvest Transplant Proc 34 2002 1086
150. H.A. Eum, S.H. Lee, and S.M. Lee Trolox C ameliorates hepatic drug metabolizing dysfunction after ischemia/reperfusion Arch Pharm Res 25 2002 940
151. E. Vardareli, T. Saricam, and T. Koken The effect of alpha-tocopherol and pentoxyfilline on ischemia-reperfusion induced liver injury in rats Hepatogastroenterology 45 1998 1505
152. M.Y. Seo, and S.M. Lee Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats J Hepatol 36 2002 72
153. H. Cerwenka, G. Khoschsorur, and H. Bacher Normothermic liver ischemia and antioxidant treatment during hepatic resections Free Radic Res 30 1999 463
154. S. Rodriguez-Reynoso, C. Leal, and E. Portilla Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: possible role of tumor necrosis factor-alpha and nitric oxide J Surg Res 100 2001 141
155. J.C. Chen, C.J. Ng, and T.F. Chiu Altered neutrophil apoptosis activity is reversed by melatonin in liver ischemia-reperfusion J Pineal Res 34 2003 260
156. W.H. Cho, D.G. Kim, and N. Murase Comparison of superoxide dismutase, allopurinol, coenzyme Q10, and glutathione for the prevention of warm ischemic injury Transplantation 50 1990 353
157. R.J. Schauer, S. Kalmuk, and A.L. Gerbes Intravenous administration of glutathione protects parenchymal and non-parenchymal liver cells against reperfusion injury following rat liver transplantation World J Gastroenterol 10 2004 864
158. R.J. Schauer, A.L. Gerbes, and D. Vonier Glutathione protects the rat liver against reperfusion injury after prolonged warm ischemia Ann Surg 239 2004 220
159. R. Chavez-Cartaya, N.V. Jamieson, and P. Ramirez Free radical scavengers to prevent reperfusion injury following experimental warm liver ischaemia. Is there a real physiological benefit? Transpl Int 12 1999 213
160. T.A. Koeppel, J.C. Thies, and T. Lehmann Improvement of hepatic microhemodynamics by N-acetylcysteine after warm ischemia Eur Surg Res 28 1996 270
161. P. Moldeus, I.A. Cotgreave, and M. Berggren Lung protection by a thiol-containing antioxidant: N-acetylcysteine Respiration 1 50 Suppl 1986 31
162. G.K. Glantzounis, W. Yang, and R.S. Koti Continuous infusion of N-acetylcysteine reduces liver warm ischaemia-reperfusion injury Br J Surg 91 2004 1330
163. J.C. Thies, J. Teklote, and U. Clauer The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation Transpl Int 1 11 Suppl 1998 S390
164. J.C. Bucuvalas, F.C. Ryckman, and S. Krug Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study Pediatr Transplant 5 2001 274
165. M.A. Weigand, J. Plachky, and J.C. Thies N-acetylcysteine attenuates the increase in alpha-glutathione S-transferase and circulating ICAM-1 and VCAM-1 after reperfusion in humans undergoing liver transplantation Transplantation 72 2001 694
166. S.L. Atalla, L.H. Toledo-Pereyra, and G.H. MacKenzie Influence of oxygen-derived free radical scavengers on ischemic livers Transplantation 40 1985 584
167. R.J. Nauta, E. Tsimoyiannis, and M. Uribe Oxygen-derived free radicals in hepatic ischemia and reperfusion injury in the rat Surg Gynecol Obstet 171 1990 120
168. L. Lambotte, Y. d'Udekem, and M. Amrani Free radicals and liver ischemia-reperfusion injury Transplant Proc 20 1988 977 (Pubitemid 18261365)
169. T. Minor, C.W. Chung, and Y. Yamamoto Evaluation of antioxidant treatment with superoxide dismutase in rat liver transplantation after warm ischemia Eur Surg Res 24 1992 333
170. H. Kimura, T. Katsuramaki, and M. Isobe Role of inducible nitric oxide synthase in pig liver transplantation J Surg Res 111 2003 28
171. O. Portakal, and M. Inal-Erden Effects of pentoxifylline and coenzyme Q10 in hepatic ischemia/reperfusion injury Clin Biochem 32 1999 461
172. E. Schutz, E. Wieland, and A. Hensel Suppression of leukocyte-enhanced cold ischemia/reperfusion injury of liver endothelium with the benzoquinone antioxidant idebenone Clin Biochem 30 1997 619
173. C. Muller, F. Dunschede, and E. Koch Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway Am J Physiol Gastrointest Liver Physiol 285 2003 G769
174. E.C. Tsimoyiannis, K.J. Moutesidou, and C.M. Moschos Trimetazidine for prevention of hepatic injury induced by ischaemia and reperfusion in rats Eur J Surg 159 1993 89
175. J.F. Su, C.J. Guo, and J.Y. Wei Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin Biomed Environ Sci 16 2003 1
176. T. Tsuda, F. Horio, and Y. Kato Cyanidin 3-O-beta-D-glucoside attenuates the hepatic ischemia-reperfusion injury through a decrease in the neutrophil chemoattractant production in rats J Nutr Sci Vitaminol (Tokyo) 48 2002 134
177. Z. Zhong, M. Froh, and H.D. Connor Prevention of hepatic ischemia-reperfusion injury by green tea extract Am J Physiol Gastrointest Liver Physiol 283 2002 G957
178. F. Amersi, S.K. Nelson, and X.D. Shen Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury Proc Natl Acad Sci U S A 99 2002 8915
179. W.D. Nguyen, D.H. Kim, and H.B. Alam Polyethylene glycol-superoxide dismutase inhibits lipid peroxidation in hepatic ischemia/reperfusion injury Crit Care 3 1999 127
180. Y. Yabe, Y. Koyama, and M. Nishikawa Hepatocyte-specific distribution of catalase and its inhibitory effect on hepatic ischemia/reperfusion injury in mice Free Radic Res 30 1999 265
181. B.R. Jeon, D.H. Yeom, and S.M. Lee Protective effect of allopurinol on hepatic energy metabolism in ischemic and reperfused rat liver Shock 15 2001 112
182. J.E. Klaunig, and L.M. Kamendulis The role of oxidative stress in carcinogenesis Annu Rev Pharmacol Toxicol 44 2004 239
183. D. Giakoustidis, G. Papageorgiou, and S. Iliadis Intramuscular administration of very high dose of alpha-tocopherol protects liver from severe ischemia/reperfusion injury World J Surg 26 2002 872
184. G.M. Sanchez, H.M. Rodriguez, and A. Giuliani Protective effect of Mangifera indica L. extract (Vimang) on the injury associated with hepatic ischaemia reperfusion Phytother Res 17 2003 197
185. G. Sener, O. Tosun, and A.O. Sehirli Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion Life Sci 72 2003 2707